Mar 17, 2025 04:30PM Akoya (AKYA) Misses Q4 EPS by 1c

Mar 5, 2025 12:10AM Piper Sandler Downgrades Akoya Biosciences Inc (AKYA) to Neutral

Feb 18, 2025 03:41PM Kent Lake Issues Letter to Quanterix (QTRX) Shareholders Regarding Opposition to the Company’s Proposed Merger with Akoya Biosciences (AKYA)

Jan 10, 2025 01:48PM SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Akoya Biosciences, Inc. Buyout

Jan 10, 2025 07:01AM Quanterix (QTRX) to acqure Akoya Biosciences (AKYA)

Dec 10, 2024 08:19AM Akoya (AKYA), NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions

Nov 19, 2024 07:55AM Akoya Biosciences Inc (AKYA) PT Lowered to $3 at Piper Sandler

Nov 15, 2024 07:45AM Piper Sandler Reiterates Overweight Rating on Akoya Biosciences Inc (AKYA)

Nov 15, 2024 06:22AM Akoya Biosciences Inc (AKYA) PT Lowered to $3.50 at Canaccord Genuity

Nov 14, 2024 05:27PM Akoya (AKYA) Misses Q3 EPS by 1c

Oct 7, 2024 08:03AM Akoya's (AKYA) Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy

Oct 3, 2024 04:01PM Akoya (AKYA) Announces Scott Mendel as Chairman of the Board of Directors

Aug 6, 2024 12:06PM Morgan Stanley Downgrades Akoya Biosciences Inc (AKYA) to Equalweight

Aug 6, 2024 06:02AM BTIG Downgrades Akoya Biosciences Inc (AKYA) to Neutral

Aug 6, 2024 02:54AM JPMorgan Downgrades Akoya Biosciences Inc (AKYA) to Neutral

Aug 5, 2024 04:09PM Akoya (AKYA) Reports In-Line Q2 EPS, provides guidance

Jul 16, 2024 06:23AM BTIG Reiterates Buy Rating on Akoya Biosciences Inc (AKYA)